Melatonin should not be offered by NHS to treat jet lag – review

14 January 2020 – BBC News

The hormone Melatonin is produced in the body during darkness to play a role with the body clock and helps to regulate sleep cycles.

It is currently available on the NHS as a treatment for various sleep problems, including in older people and children with attention deficit/hyperactivity disorder (ADHD).

In 2019 two melatonin products were licensed as a prescription medication for managing short-term jet lag by the UK’s Medicines and Healthcare Products Regulatory Agency but an independent drug review for the hormone by the Drug and Therapeutics Bulletin – a publication that summarises and weighs the evidence for medicines and treatments – has concluded the hormone should not be prescribed for jet lag on the NHS.


%d bloggers like this: